Pharmaceutical Dosage Form Comprising 6'-Fluoro-(N-Methyl- Or N,N-Dimethyl-)-4-Phenyl-4,9'-Dihydro-3'H-Spiro[Cylohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine - EP2600839
The patent EP2600839 was granted to Grnenthal on Jan 10, 2018. The application was originally filed on Aug 4, 2011 under application number EP11746175A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".
EP2600839
- Application Number
- EP11746175A
- Filing Date
- Aug 4, 2011
- Status
- No Opposition Filed Within Time Limit
- Nov 16, 2018
- Publication Date
- Jan 10, 2018
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents